wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28087213-A5481758-A992-471E-B939-A79C56D43C54
Q28087213-A5481758-A992-471E-B939-A79C56D43C54
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28087213-A5481758-A992-471E-B939-A79C56D43C54
Secondary mutations as mediators of resistance to targeted therapy in leukemia
P2860
Q28087213-A5481758-A992-471E-B939-A79C56D43C54
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28087213-A5481758-A992-471E-B939-A79C56D43C54
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d8e8df2506338aa95cb996b23897043128e52a2b
P2860
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure